Oligosaccharides interfere with the establishment and progression of experimental pneumococcal pneumonia.
Oligosaccharides that block the adherence of bacteria to epithelial cells in vitro--lacto-N-neotetraose (LNnT) and its alpha2-3- and alpha2-6-sialylated derivatives--were tested for their abilities to attenuate the course of pneumococcal pneumonia and to prevent colonization of the nasopharynx in animal models. Intratracheal administration of these agents concurrently with bacteria dramatically decreased pneumococcal load in the lungs of rabbits and conferred protection from bacteremia. The oligosaccharides ameliorated pneumonia and bacteremia when given therapeutically 24 h after infection was established. When administered intranasally, neoglycoconjugates of the active oligosaccharides prevented colonization of the nasopharynx of infant rats. In addition to in vitro anti-adherence properties, LNnT acted directly on cultured lung epithelial cell lines to induce changes such that pneumococcal adherence was prevented for prolonged periods. These activities encourage continued development of oligosaccharides as a class of potentially preventive and therapeutic agents for infectious diseases.
Idänpään-Heikkilä
I
I
Rockefeller University, and Department of Radiology, New York Hospital-Cornell Medical Center, New York, USA.
Simon
P M
PM
Zopf
D
D
Vullo
T
T
Cahill
P
P
Sokol
K
K
Tuomanen
E
E
D000818:Animals; D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology; D001422:Bacterial Adhesion / Q000187:drug effects; D002240:Carbohydrate Sequence; D002460:Cell Line; D008168:Lung / Q000187:drug effects / Q000382:microbiology; D008969:Molecular Sequence Data; D009305:Nasopharynx / Q000382:microbiology; D009844:Oligosaccharides / Q000494:pharmacology*; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy* / Q000517:prevention & control; D011817:Rabbits; D051381:Rats; D013296:Streptococcus pneumoniae / Q000187:drug effects*
D009844:Oligosaccharides; C013084:lacto-N-neotetraose